Condition
Human Papillomavirus (HPV) Vaccines
Total Trials
2
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
4 treatments under study, led by Protect Me 4 Application External Quality Improvement Support
Research Leaders
7 sponsors active, led by University of Florida
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Showing 2 of 2 trials
NCT03429413Not ApplicableNot Yet RecruitingPrimary
Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial
NCT07200414Not ApplicableCompleted
Strengthening HPV Vaccination and Adolescent Health Research Program in Nigeria (SHARP)
Showing all 2 trials
Research Network
Common Treatments
- Protect Me 4 Application External Quality Improvement Support1
- Integrated Adolescent Health Package1
- Protect Me 4 Application Alone1
- Routine Government Health Services1
Active Sponsors
- University of Florida1
- Direct Consulting and Logistics1
- National Cancer Institute (NCI)1
- Jhpiego1
- Patient-Centered Outcomes Research Institute1
Top Investigators
Johns Hopkins University
University of Florida
Related Conditions
- Adolescent Health Services1
- Human Papillomavirus Hpv Infections1
- Human Papillomavirus Hpv Vaccine1